Academia
The Right to Try Act, signed into law by President Donald Trump last spring, may be seeing its first fruits. A California brain cancer patient who did not qualify for participation in a clinical trial will get the chance to see if an experimental glioblastoma treatment will save his life.
CRISPR, aging, food health, artificial intelligence and more will be some of the key areas of conversation for the coming year, researchers say.
Brain plasticity refers to the brain’s ability to change throughout life. When young, the brain is highly plastic, but becomes less so as we age. Too much plasticity can be a problem, but it’s necessary for the brain’s ability to repair itself or reorganize itself after injury or when learning new things.
Moderna’s clinical and business update at the JP Morgan Healthcare Conference led the newly public company shares to pop 4.2 percent, a welcome change.
Rice U. engineer honored for inventions that diagnose cancer, save babies
The Lead Discovery Center (LDC) has teamed up with McGill University in Canada, Institut National de la Santé Et de la Recherche Médicale (INSERM) in France and Semmelweis University in Hungary to discover new approaches for the treatment of alpha-1 antitrypsin deficiency (ATD), a rare genetic disorder that lead to severe lung and liver diseases.
As a valued member of our BioSpace community, we are eager to hear more from you and other readers in 2019. Let us know which topics you want to hear more about.
Consumption of one egg every day seems to associate with a blood metabolite profile that is related to a lower risk of type 2 diabetes, a new study conducted in the University of Eastern Finland shows.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Follow-up investigations by the Wall Street Journal suggest that He Jiankui’s story may be just the tip of the iceberg of sloppy and unmonitored clinical trials using CRISPR in China.
PRESS RELEASES